孟加拉国、巴基斯坦和斯里兰卡农村地区高血压管理的多组分干预与常规照护对比:整群随机对照试验研究方案
本研究为在孟加拉国、巴基斯坦和斯里兰卡农村社区开展的整群随机对照试验方案,拟纳入2550名≥40岁高血压患者,比较多组分干预与常规照护对收缩压的影响及成本效果。主要结局为随机化后24个月收缩压较基线的变化,并计算避免每伤残调整生命年的增量成本。
要点
- 多组分干预包含社区健康工作者家访教育、血压监测与清单式转诊、公私机构医务人员培训、高血压分诊与协调员设置及融资补偿模型五个部分。
- 常规照护为社区现有服务,不附加任何额外培训。
- 主要结局为随机化后24个月收缩压较基线的变化,并评估成本效果。
核心结论
- 该研究将提供多组分干预策略在农村公共卫生基础设施中控制血压的有效性和成本效果证据;若显示成功,多组分干预可能成为应对低资源国家心血管疾病发病率上升的长期可持续策略。
研究设计与样本
- 分层整群随机对照试验,包含定性组分以评估过程和利益相关者反馈。
- 在孟加拉国、巴基斯坦和斯里兰卡的30个农村社区纳入2550名年龄≥40岁的高血压患者。
- 高血压定义为基于两个不同日期三次测量中最后两次均值收缩压≥140 mmHg或舒张压≥90 mmHg,或正在接受降压治疗。
主要发现
- 多组分干预包含五个组分:政府社区健康工作者提供家访健康教育;使用清单进行血压监测并逐步转诊至受过培训的全科医生;培训公立和私立服务提供者管理高血压并使用清单;在政府诊所指定高血压分诊柜台和高血压照护协调员;融资模型补偿额外健康服务并向血压控制不佳的低收入个体提供补贴。
- 常规照护包括社区现有服务,不附加任何额外培训。
- 主要结局为随机化后24个月随访时收缩压较基线的变化。
- 将计算多组分干预避免每心血管疾病伤残调整生命年的增量成本。
- 将访谈利益相关者,包括政策制定者、相关规划省级和地区级协调员、医生、社区健康工作者、关键社区领袖、高血压个体及其家庭成员。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High blood pressure (BP) is the leading attributable risk for cardiovascular disease (CVD). In rural South Asia, hypertension continues to be a significant public health issue with sub-optimal BP control rates. The goal of the trial is to compare a multicomponent intervention (MCI) to usual care to evaluate the effectiveness and cost-effectiveness of the MCI for lowering BP among adults with hypertension in rural communities in Bangladesh, Pakistan and Sri Lanka. METHODS/DESIGN: This study is a stratified, cluster randomized controlled trial with a qualitative component for evaluation of processes and stakeholder feedback. The MCI has five components: (1) home health education by government community health workers (CHWs), (2) BP monitoring and stepped-up referral to a trained general practitioner using a checklist, (3) training public and private providers in management of hypertension and using a checklist, (4) designating hypertension triage counter and hypertension care coordinators in government clinics and (5) a financing model to compensate for additional health services and provide subsidies to low income individuals with poorly controlled hypertension. Usual care will comprise existing services in the community without any additional training. The trial will be conducted on 2550 individuals aged ≥40 years with hypertension (with systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg, based on the mean of the last two of three measurements from two separate days, or on antihypertensive therapy) in 30 rural communities in Bangladesh, Pakistan and Sri Lanka. The primary outcome is change in systolic BP from baseline to follow-up at 24 months post-randomization. The incremental cost of MCI per CVD disability-adjusted life years averted will be computed. Stakeholders including policy makers, provincial- and district-level coordinators of relevant programmes, physicians, CHWs, key community leaders, hypertensive individuals and family members in the identified clusters will be interviewed. DISCUSSION: The study will provide evidence of the effectiveness and cost-effectiveness of MCI strategies for BP control compared to usual care in the rural public health infrastructure in South Asian countries. If shown to be successful, MCI may be a long-term sustainable strategy for tackling the rising rates of CVD in low resourced countries. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02657746 . Registered on 14 January 2016.
引用
- Jafar TH, Jehan I, de Silva HA, et al. Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial. Trials. 2017. PMID: 28606184. doi:10.1186/s13063-017-2018-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。